Technology billionaire Elon Musk - one of the close allies of US President Donald Trump - is facing serious drug abuse allegations, according to an article by the New York Times citing sources.
RT reported that the New York Times said that Mr. Musk consumed a large amount of ketamine and many other stimulants far exceeding the usual prescription level. Although he previously admitted to using ketamine every two weeks to treat depression, the New York Times said that his current condition has developed into a serious habit, with a "regular, sometimes daily" frequency of use, even combined with psychedelic ecstasy and mushrooms.
The newspaper's source said that Musk carries a box of medicine containing about 20 pills a day, including Adderall - a stimulant used to treat attention deficit hyperactivity disorder (ADHD).
Previously, in 2018, the New York Times reported that some Tesla board members were concerned about Musk's use of Ambien - a sleeping drug. More recently, the Wall Street Journal revealed that senior leaders at SpaceX and Tesla also expressed concerns that Musk may use LSD and cocaine.
The report was published not long after Musk announced his withdrawal from his leadership role at the Department of Government Efficiency (DOGE) - a group specializing in cutting federal spending on waste. However, he affirmed that his withdrawal does not mark the end of the DOGE, and pledged to continue supporting the president as an advisor and friend.
When asked about the allegations at a press conference with President Trump at the White House, Musk refused to answer directly and criticized the New York Times as a Pulitzer Prize-winning newspaper for reporting false information about Russiagate.
He also stressed that no trace of drugs or alcohol was found in the results of three-year testing at SpaceX. However, concerns about Mr. Musk's overuse of stimulants continue to attract the attention of the public and the media.
